Abbott Architect SARS-CoV-2 IgM Serology Assay

**Semantic type:** Laboratory Procedure

**Definition:** A chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Abbott ARCHITECT i system. The presence of IgM antibodies may be associated with recent infection or may assist with the evaluation of disease course.